We are live on ! Find out more
AGN

Allergan plc
AGN

Delisted

AGN was delisted on the 8th of May, 2020.

1,089 hedge funds and large institutions have $105B invested in Allergan plc in 2015 Q1 according to their latest regulatory filings, with 298 funds opening new positions, 549 increasing their positions, 185 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

645% more first-time investments, than exits

New positions opened: 298 | Existing positions closed: 40

197% more repeat investments, than reductions

Existing positions increased: 549 | Existing positions reduced: 185

63% more capital invested

Capital invested by funds: $64.6B → $105B (+$40.6B)

48% more funds holding in top 10

Funds holding in top 10: 123182 (+59)

30% more funds holding

Funds holding: 8401,089 (+249)

15% more call options, than puts

Call options by funds: $2.92B | Put options by funds: $2.55B

Holders
1,089
Holders Change
+249
Holders Change %
+29.64%
% of All Funds
29.01%
Holding in Top 10
182
Holding in Top 10 Change
+59
Holding in Top 10 Change %
+47.97%
% of All Funds
4.85%
New
298
Increased
549
Reduced
185
Closed
40
Calls
$2.92B
Puts
$2.55B
Net Calls
+$370M
Net Calls Change
-$860M
Name Holding Trade Value Shares
Change
Change in
Stake
First Eagle Investment Management
51
First Eagle Investment Management
New York
$468M +$113M +396,990 +34%
Neuberger Berman Group
52
Neuberger Berman Group
New York
$465M +$181M +634,934 +69%
YCMGA
53
York Capital Management Global Advisors
New York
$455M +$49.3M +172,792 +13%
BRC
54
Blue Ridge Capital
New York
$436M -$45.3M -159,000 -10%
VAM
55
Visium Asset Management
New York
$435M +$209M +734,012 +101%
PSCM
56
Pershing Square Capital Management
New York
$401M +$384M +1,348,358 New
CM
57
Corvex Management
New York
$399M +$19.4M +68,100 +5%
New York State Common Retirement Fund
58
New York State Common Retirement Fund
New York
$397M +$99M +347,078 +35%
Coatue Management
59
Coatue Management
New York
$393M +$102M +357,295 +37%
FTCM
60
Fir Tree Capital Management
New York
$390M +$61.5M +215,758 +20%
VOYA Investment Management
61
VOYA Investment Management
Georgia
$386M +$122M +429,001 +49%
Ameriprise
62
Ameriprise
Minnesota
$382M +$4.23M +14,820 +1%
Edgewood Management
63
Edgewood Management
Connecticut
$360M +$345M +1,209,179 New
MC
64
Montag & Caldwell
Georgia
$353M +$144M +504,102 +74%
BIM
65
BlackRock Investment Management
Delaware
$352M +$152M +533,544 +82%
BlackRock
66
BlackRock
New York
$347M +$101M +354,037 +44%
Macquarie Group
67
Macquarie Group
Australia
$337M +$261M +915,084 +420%
Allianz Asset Management
68
Allianz Asset Management
Germany
$324M +$76.8M +269,534 +33%
MAA
69
Managed Account Advisors
New Jersey
$318M +$58.9M +206,562 +24%
SO
70
STRS Ohio
Ohio
$317M +$47.6M +166,974 +19%
TA
71
Teachers Advisors
New York
$315M +$86.1M +302,045 +40%
DCP
72
DSM Capital Partners
Florida
$309M +$296M +1,038,601 New
Westfield Capital Management
73
Westfield Capital Management
Massachusetts
$309M -$6.16M -21,613 -2%
Charles Schwab
74
Charles Schwab
California
$297M +$98.7M +346,335 +53%
FCM
75
Farallon Capital Management
California
$293M +$262M +919,914 +1,407%

AGN Hedge Fund Activity: Q1 2015 in Review

1,089 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q1 2015, worth a combined $105B — up 63% from $64.6B a quarter earlier.

Buyers outnumbered sellers: 298 funds opened new AGN positions and 40 closed out — a net gain of 258 holders — while 549 added to existing stakes and 185 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $2.6B. The largest seller was Renaissance Technologies, exiting entirely with an estimated $117M sold.

  • 1,089 institutional investors held Allergan plc (AGN) as of Q1 2015, up from 840 in Q4 2014.
  • Funds reported $105B of Allergan plc stock for Q1 2015, up 63% quarter-over-quarter.
  • 298 funds opened new Allergan plc positions in Q1 2015 and 40 closed out, a net change of +258 holders.
  • The largest Allergan plc buyer in Q1 2015 was T. Rowe Price Associates, an estimated $2.6B added.
  • The largest Allergan plc seller in Q1 2015 was Renaissance Technologies, an estimated $117M sold.

Based on aggregated 13F filings for Q1 2015.